CPHI stock · PG stock

CPHI vs PG

China Pharma Holdings Inc (CPHI) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.

China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.

Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.

Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.

Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.

CPHI currently screens at market cap $29.0M. PG currently screens at market cap $373.53B and trailing P/E 25.3.

Not investment advice. Open the CPHI and PG stock pages for the full models.

Not investment advice.

Popular Stock Comparisons